IL-8/CXCL8 抗体 (YA5190)

IL-8/CXCL8 Antibody (YA5190) is a Mouse-derived and non-conjugated monoclonal antibody, targeting to IL-8/CXCL8.

IL-8/CXCL8蛋白作为关键的趋化因子，通过吸引中性粒细胞、嗜碱性粒细胞和T细胞来有效清除病原体并保护宿主免受感染，从而在介导炎症反应中发挥核心作用。它还对中性粒细胞激活有显着贡献。IL-8/CXCL8 响应炎症刺激而释放，通过与 G 蛋白偶联受体 CXCR1 和 CXCR2（主要存在于中性粒细胞、单核细胞和内皮细胞中）结合来发挥作用。G 蛋白异源三聚体（α、β、γ 亚基）与 CXCR1/CXCR2 受体组成型结合，IL-8 激活导致 Gα（中性粒细胞中的 GNAI2）释放 β 和 γ 亚基，随后激活下游信号通路，包括 PI3K 和 MAPK 通路。IL-8/CXCL8 形成同型二聚体，这种二聚体被蜱 evasin-3 破坏。此外，IL-8/CXCL8 通过其 Link 结构域与 TNFAIP6 相互作用，这种相互作用干扰趋化因子与糖胺聚糖的结合，表明其在调节炎症微环境中趋化因子活性中发挥调节作用。

3576 [NCBI]

P10145

IL-8/CXCL8 抗体 (YA5190)

; Ala-IL-8; 77; Ser-IL-8; 72; 3 10C; 310C; AMCF 1; AMCF1; b ENAP; Bbeta thromboglobulin like protein; Beta thromboglobulin like protein; C-X-C motif chemokine 8; CXC chemokine ligand 8; CXCL 8; CXCL8; Emoctakin; GCP 1; GCP-1; GCP/IL-8 protein I; GCP/IL-8 protein II; GCP/IL-8 protein III; GCP/IL-8 protein IV; GCP/IL-8 protein V; GCP/IL-8 protein VI; GCP1; Granulocyte chemotactic protein 1; IL 8; IL-8; IL-8; 1-77; IL-8; 9-77; IL8; IL8/NAP1 form I; IL8/NAP1 form II; IL8/NAP1 form III; IL8/NAP1 form IV; IL8/NAP1 form V; IL8/NAP1 form VI; IL8_HUMAN; Inteleukin 8; Interleukin8; K 60; K60; LECT; LUCT; Lymphocyte derived neutrophil activating factor; Lymphocyte-derived neutrophil-activating factor; LYNAP; MDNCF; MDNCF-b; MDNCF-c; MONAP; Monocyte derived neutrophil activating peptide; Monocyte derived neutrophil activating protein; Monocyte derived neutrophil chemotactic factor; Monocyte-derived neutrophil chemotactic factor; Monocyte-derived neutrophil-activating peptide; NAF; NAP 1; NAP-1; NAP1; Neutrophil activating factor; Neutrophil activating peptide 1; Neutrophil activating protein 1; Neutrophil-activating factor; Neutrophil-activating protein 1; Protein 3 10C; Protein 3-10C; SCYB 8; SCYB8; Small inducible cytokine subfamily B member 8; T cell chemotactic factor; T-cell chemotactic factor; TSG 1; TSG1;

Human

WB: 1:500

Shipping with blue ice.